参考文献/References:
[1]尚新芳,薛蓉,任丽平.化疗患者留置经外周静脉置入中心静脉导管后导管相关性感染的危险因素[J].中国感染与化疗杂志,2022,22(2):151-155.[2]Nozomi M,Toyoaki M,Toshiyuki T,et al.Safety Assessment of Peripherally Inserted Central Venous Catheter: A Retrospective Single-center Study to Compare Cancer and Non-cancer Patients[J].Palliative Care Research,2017,12(1):169-174.[3]韩娜,孟宪静.肺癌患者PICC导管相关血流感染的影响因素及其风险管理体系建立效果分析[J].中华现代护理杂志,2020,26(25):3440-3445.[4]王道军,刘静,左名秀,等.肿瘤患者经外周放置中心静脉导管相关性感染的病原菌分布、耐药性及影响因素分析[J].现代生物医学进展,2019,19(24):4727-4731.[5]中华人民共和国卫生部.医院感染诊断标准(试行)[J].中华医学杂志,2001,81(5):314-320.[6]Mollee P,Okano S,Abro E,et al.Catheter-associated bloodstream infections in adults with cancer: a prospective randomized controlled trial[J].J Hosp Infect,2020,106(2):335-342.[7]叶冠军,孙雅儿,陆萍,等.行PICC患者血栓和相关性血流感染发生的影响因素研究[J].中华全科医学,2019,17(6):1037-1041.[8]Zhou L,Wang M,Li A.Analysis of Risk Factors of Peripherally Inserted Central Catheter Induced Catheter-related Infection in Patients with Leukemia[J].Iran J Public Health,2017,46(4):485-490.[9]骆莹莹,林莉,戴志辉.ICU患者经外周静脉置入中心静脉导管相关性感染的危险因素分析[J].中国卫生检验杂志,2018,28(2):220-221,243.[10]闵贝贝,韩永红,胡明.肿瘤患者经外周静脉置入中心静脉导管相关性感染的发生情况和危险因素[J].广西医学,2018,40(16):1900-1903.[11]Krein SL,Saint S,Trautner BW,et al.Patient-reported complications related to peripherally inserted central catheters: a multicentre prospective cohort study[J].BMJ Qual Saf,2019,28(7):574-581.[12]张畅英.肿瘤患者经外周静脉置入中心静脉导管相关性感染的危险因素及护理对策[J].中国全科医学,2017,20(S1):177-179.[13]Liu Z,Chen J,Zan L,et al.Exploring the Risk Factors of Thrombosis and Bloodstream Infections in Peripherally Inserted Central Catheter (PICC) Patients[J].Journal of Biomaterials and Tissue Engineering,2019,9(7):929-934.[14]唐颖嘉,潘文彦,蔡诗凝.ICU患者PICC导管相关性感染影响因素分析及应对措施[J].中国实用护理杂志,2017,33(32):2526-2529.[15]Pu YL,Li ZS,Zhi XX,et al.Complications and Costs of Peripherally Inserted Central Venous Catheters Compared With Implantable Port Catheters for Cancer Patients: A Meta-analysis[J].Cancer Nurs,2020,43(6):455-467.[16]寿月华,王笑娟,徐芳娟.化疗患者PICC导管相关性感染危险因素[J].中华医院感染学杂志,2020,30(16):2470-2473.[17]马清华,邓珍珍,丁婷婷,等.51例乳腺癌化疗患者PICC导管相关感染的危险因素分析[J].中华肿瘤防治杂志,2020,27(16):1305-1308.[18]梁永红,陈素珍,冉丽娜,等.恶性肿瘤PICC患者导管感染与CRP、 PCT等指标的相关性分析[J].中国实验诊断学,2019,23(9):1553-1555.[19]刘佳,和茵,刘鑫.肿瘤患者PICC导管相关性感染的危险因素及护理对策[J].昆明医科大学学报,2021,42(1):173-176.[20]许立薇,赵心阳,张晓春.股静脉置入PICC术后预防导管相关性血流感染的循证护理研究[J].中国医学装备,2019,16(5):94-97.[21]鲁梦舒,廖婧.专业化护理在PICC导管相关血流感染预防效果分析[J].贵州医药,2018,42(7):889-890.[22]张芹,刘亚琼.肿瘤患者PICC导管相关性感染的危险因素分析及应对策略[J].医学临床研究,2019,36(1):159-160.[23]冯静英,顾丽英,鲁林花,等.综合干预方案对乳腺癌患者PICC导管相关血流感染的影响[J].中华医院感染学杂志,2017,27(22):5141-5144.[24]He K,Wan Y,Xian S.Risk analysis on infection caused by peripherally inserted central catheter for bone tumor patients[J].J Cancer Res Ther,2018,14(1):90-93.[25]孙滨海,吴妮慧,周卓迪,等.老年患者PICC导管相关性血流感染集束化护理效果评价[J].老年医学与保健,2017,23(1):12-14,22.[26]俞素琴.肿瘤患者PICC相关感染危险因素与护理措施[J].中医药管理杂志,2017,25(19):139-141.